Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2

被引:53
作者
Ahsan, MK
Masutani, H
Yamaguchi, Y
Kim, YC
Nosaka, K
Matsuoka, M
Nishinaka, Y
Maeda, M
Yodoi, J
机构
[1] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Inst Virus Res, Res Ctr Acquired Immunofef Syndrome, Sakyo Ku, Kyoto, Japan
关键词
HTLV-I; ATL; TBP-2/; VDUP1; DNA-methylation; histone deacetylation; interleukin-2;
D O I
10.1038/sj.onc.1209256
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transition from interleukin-2 (IL-2)-dependent to IL-2-independent growth is considered one of the key steps in the transformation of human T-cell leukemia virus type-I (HTLV-I)-infected T cells. The expression of thioredoxin-binding protein-2 (TBP-2) is lost during the transition of HTLV-I-infected T-cell lines. Here, we analysed the mechanism of loss of TBP-2 expression and the role of TBP-2 in IL-2-dependent growth in the in vitro model to investigate multistep transformation of HTLV-I. CpGs in the TBP-2 gene are methylated in IL-2-independent but not in IL-2-dependent cells. Sequential treatment with 5-aza-2'-deoxycytidine and a histone deacetylase inhibitor augmented histone acetylation and TBP-2 expression, suggesting that loss of TBP-2 expression is due to DNA methylation and histone deacetylation. In IL-2-dependent cells, a basal level of TBP-2 expression was maintained by IL-2 associated with cellular growth, whereas TBP-2 expression was upregulated on deprivation of IL-2 associated with growth suppression. Overexpression of TBP-2 in IL-2-independent cells suppressed the growth and partially restored responsiveness to IL-2. Knockdown of TBP-2 caused the IL-2-dependent cells to show partial growth without IL- 2. These results suggested that epigenetic silencing of the TBP-2 gene results in a loss of responsiveness to IL- 2, contributing to uncontrolled IL- 2- independent growth in HTLV-I-infected T-cell lines.
引用
收藏
页码:2181 / 2191
页数:11
相关论文
共 29 条
[1]   The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin [J].
Butler, LM ;
Zhou, XB ;
Xu, WS ;
Scher, HI ;
Rifkind, RA ;
Marks, PA ;
Richon, VM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11700-11705
[2]   Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer [J].
Cameron, EE ;
Bachman, KE ;
Myöhänen, S ;
Herman, JG ;
Baylin, SB .
NATURE GENETICS, 1999, 21 (01) :103-107
[3]   ISOLATION AND CHARACTERIZATION OF A NOVEL CDNA FROM HL-60 CELLS TREATED WITH 1,25-DIHYDROXYVITAMIN D-3 [J].
CHEN, KS ;
DELUCA, HF .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (01) :26-32
[4]   Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation [J].
Coombes, MM ;
Briggs, KL ;
Bone, JR ;
Clayman, GL ;
El-Naggar, AK ;
Dent, SYR .
ONCOGENE, 2003, 22 (55) :8902-8911
[5]   CPG ISLANDS IN VERTEBRATE GENOMES [J].
GARDINERGARDEN, M ;
FROMMER, M .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 196 (02) :261-282
[6]  
Goldberg SF, 2003, CANCER RES, V63, P432
[7]   VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression [J].
Han, SH ;
Jeon, JH ;
Ju, HR ;
Jung, U ;
Kim, KY ;
Sook, H ;
Yoo, HS ;
Lee, YH ;
Song, KS ;
Hwang, HM ;
Na, YS ;
Yang, Y ;
Lee, KN ;
Choi, I .
ONCOGENE, 2003, 22 (26) :4035-4046
[8]  
HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237
[9]   Life, death, and tax: Role of HTLV-I oncoprotein in genetic instability and cellular transformation [J].
Jeang, KT ;
Giam, CZ ;
Majone, F ;
Aboud, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) :31991-31994
[10]  
Maeda M, 1992, Hum Cell, V5, P70